(Total Views: 586)
Posted On: 08/13/2020 2:22:08 PM
Post# of 153822
I agree with you. However, are the efforts futile because of OTC? As long as we're listed on this exchange will *anyone* listen or take LL seriously? Thus far, it doesn't seem so. As soon as people learn it's OTC they tune out.
A few here have compounded these concerns with anecdotes about countless medical professionals who couldn't care less. They've got their Remdesivir and they're content with its inadequacies.
While Mulholland is focused on uplisting, NP should pour every resource into getting the s/c trial fully enrolled. If EUA doesn't happen, we need to expedite the s/c trial. Nothing we can do shorten the 28 days, but the sooner we hit 195 patients the sooner those 28 days can start ticking...
A few here have compounded these concerns with anecdotes about countless medical professionals who couldn't care less. They've got their Remdesivir and they're content with its inadequacies.
While Mulholland is focused on uplisting, NP should pour every resource into getting the s/c trial fully enrolled. If EUA doesn't happen, we need to expedite the s/c trial. Nothing we can do shorten the 28 days, but the sooner we hit 195 patients the sooner those 28 days can start ticking...
(1)
(0)
